BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 36785881)

  • 1. STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells.
    Pillemer BB; Qi Z; Melgert B; Oriss TB; Ray P; Ray A
    J Immunol; 2009 Jul; 183(1):155-63. PubMed ID: 19535633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L2 controls peripherally induced regulatory T cells by maintaining metabolic activity and Foxp3 stability.
    Hurrell BP; Helou DG; Howard E; Painter JD; Shafiei-Jahani P; Sharpe AH; Akbari O
    Nat Commun; 2022 Aug; 13(1):5118. PubMed ID: 36045140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.
    Santagata S; Rea G; Bello AM; Capiluongo A; Napolitano M; Desicato S; Fragale A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Persico F; Di Napoli M; Di Maro S; Feroce F; Azzaro R; Gabriele L; Longo N; Pignata S; Perdonà S; Scala S
    Br J Cancer; 2024 May; ():. PubMed ID: 38704478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota.
    Zhang H; Shi Y; Lin C; He C; Wang S; Li Q; Sun Y; Li M
    Front Immunol; 2023; 14():1338918. PubMed ID: 38288125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-helper cells flexibility: the possibility of reprogramming T cells fate.
    Khantakova JN; Sennikov SV
    Front Immunol; 2023; 14():1284178. PubMed ID: 38022605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.
    Horwitz DA; Zheng SG; Gray JD
    Trends Immunol; 2008 Sep; 29(9):429-35. PubMed ID: 18676178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
    Giri PS; Mistry J; Dwivedi M
    J Immunol Res; 2022; 2022():6952299. PubMed ID: 36164321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT6 controls the stability and suppressive function of regulatory T cells.
    Arroyo-Olarte RD; Rivera-Rugeles A; Nava-Lira E; Sánchez-Barrera Á; Ledesma-Soto Y; Saavedra R; Armas-López L; Terrazas LI; Ávila-Moreno F; Leon-Cabrera S
    Eur J Immunol; 2023 May; 53(5):e2250128. PubMed ID: 36785881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
    Arroyo-Olarte RD; Flores-Castelán JC; Armas-López L; Escobedo G; Terrazas LI; Ávila-Moreno F; Leon-Cabrera S
    Inflammation; 2024 May; ():. PubMed ID: 38700792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT6 Is Critical for the Induction of Regulatory T Cells In Vivo Controlling the Initial Steps of Colitis-Associated Cancer.
    Delgado-Ramirez Y; Ocaña-Soriano A; Ledesma-Soto Y; Olguín JE; Hernandez-Ruiz J; Terrazas LI; Leon-Cabrera S
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor.
    Takaki H; Ichiyama K; Koga K; Chinen T; Takaesu G; Sugiyama Y; Kato S; Yoshimura A; Kobayashi T
    J Biol Chem; 2008 May; 283(22):14955-62. PubMed ID: 18400747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2.
    Knosp CA; Schiering C; Spence S; Carroll HP; Nel HJ; Osbourn M; Jackson R; Lyubomska O; Malissen B; Ingram R; Fitzgerald DC; Powrie F; Fallon PG; Johnston JA; Kissenpfennig A
    J Immunol; 2013 Apr; 190(7):3235-45. PubMed ID: 23455506
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.